Crossmark

The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s00404-016-4256-x

Published Online: 2016-12-03

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Xia

Deng, Fei

Lv, Mengmeng

Chen, Xiaoxiang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81472441)

Natural Science Foundation of Jiangsu Province (BK20131439)

six major talent summit (2013-wsn-62)
License Information

License valid from 2016-12-03